HLA DQ Genotyping for Celiac Disease
Celiac disease is an autoimmune disorder of the gastrointestinal tract that occurs in genetically predisposed people of all ages from middle infancy onward. Symptoms include pain and discomfort in the digestive tract, chronic constipation, diarrhea, failure to thrive, anemia and fatigue. Vitamin deficiencies are often noted in people with celiac disease owing to the reduced ability of the small intestine to properly absorb nutrients from food. The only known effective treatment is a lifelong gluten-free diet.
Celiac disease is multifactorial with multiple genetic contributors, including HLA-DQ. HLA-DQ is a part of the MHC class II antigen-presenting receptor (also called the human leukocyte antigen) system and distinguishes cells between self and non-self for the purposes of the immune system. The two subunits of the HLA-DQ protein are encoded by the HLA-DQA1 and HLA-DQB1 genes, located on the short arm of the sixth chromosome.
HLA-DQ genotyping can aid in the diagnosis of celiac disease. Approximately 95% of people with celiac disease have a two-gene HLA-DQ2 haplotype referred to as DQ2.5 haplotype. This haplotype is composed of DQA1*05 and DQB1*02, which encode the two subunits, DQ α5 and DQ β2.
Approximately 5% of people with celiac disease bear the DQ8.3 haplotype composed of DQA1*03 and DQB1*03:02, which encode the two subunits, DQ α3 and DQ β8.
In rare cases of celiac disease the DQ2.2 haplotype has been detected. This haplotype is composed of DQA1*02 and DQB1*02, which encode the two subunits, DQ α2 and DQ β2. In these cases, the haplotype is usually homozygous.
However, about 20–30% of people without celiac disease also have these alleles. This suggests additional factors are needed for celiac disease to develop; that is, the predisposing HLA allele is necessary but not sufficient to develop celiac disease.
- As an aid in diagnosis of Celiac Disease
- Risk assessment for Celiac Disease
- The presence of HLA-DQ2 or DQ8 is considered necessary, but not sufficient, for a diagnosis of celiac disease and additional diagnostic testing is required TO CONFIRM celiac disease if one of these haplotypes is present.
- HLA DQ2 (as DQA1\05-DQB1\02) is present in approximately 95% of patients with biopsy proven celiac disease.
- Sensitivity = 94%
- Specificity = 73%
- HLA DQ8 (as DQA1\03-DQB1\03:02(8)) is present in approximately 5% of patients with biopsy proven celiac disease.
- Sensitivity = 12%
- Specificity = 81%
- Rarely patients with DQA1\02-DQB1\02 may present with celiac disease but in such situations, the haplotype is usually homozygous.
- ABSENCE of all of these haplotypes RULES OUT celiac disease.
Negative for HLA-DQA*05, HLA-DQB*02, or HLA-DQB*03:02.
Blood
Whole blood (ACD yellow top tube is preferred, EDTA lavender top tube also accepted).
Stability
- Ambient: 5 days
- Refrigerated: 7 days
- Am J Gastroenterol. 2013;108:656–676. [PMID: 23609613]
- Ann Intern Med. 2007;147(5):294–302. [PMID: 17785484]
- Proc Natl Acad Sci. 2004; Mar 23;101(12):4175-9. [PMID: 15020763]
- Scand J Gastroenterol. 2997;42(1):48–53. [PMID: 17190762]
- Hum Immunol. 2003;64(4):469–77. [PMID: 12651074]
- Hum Immunol. 2002;63(8):677–82. [PMID: 12121676]